close
close

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 ml) Auto-injector Page 1

Posted on by Vaseline
scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 ml) Auto-injector Page 1

SCP-111 Autoinjector achieved primary pharmacokinetic and secondary pharmacodynamic endpoints

The auto-injector is being developed to deliver a subcutaneous injection of furosemide as an alternative option to the FDA-approved FUROSCIX on-body infusor presentation

Company targets submission of Supplemental New Drug Application (sNDA) to FDA by late 2024

Related Posts